03:33 AM EDT, 05/12/2026 (MT Newswires) -- (Updates to add currency-adjusted outlook)

Bayer (BAYN.F) said Tuesday its net income for the first quarter increased, while net sales declined year over year.

Net income after tax attributable to stockholders for the three months ended March 31 was 2.76 billion euros, compared with 1.30 billion euros earlier. EPS moved to 2.81 euros from 1.32 euros.

The German drugmaker's net sales were 13.41 billion euros, compared with 13.74 billion euros a year ago.

For full-year 2026, Bayer confirmed its currency-adjusted guidance for sales of 45 billion euros to 47 billion euros and core EPS of 4.30 euros to 4.80 euros.

Based on closing exchange rates as of March 31, Bayer raised its sales forecast to 44.5 billion euros to 46.5 billion euros from 44 billion euros to 46 billion euros previously, while core EPS is expected at 4.10 euros to 4.60 euros, compared with the prior guidance of 4 euros to 4.50 euros, reflecting currency effects alone.